The pharmaceutical industry at risk: how excessive government regulation stifles innovation.

Abstract

In the fall of 2006, I published a book, Overdose: How Excessive Government Regulation Stifles Pharmaceutical Innovation. The book goes against the conventional wisdom found in the academic and popular literature on the topic by offering a more sympathetic view of the pharmaceutical industry.

Full Text

• DOI - Clinical pharmacology and therapeutics (DOI)
• EBSCO - full-text online (subscription/membership/fee required)
• Nature Publishing Group - full-text online (subscription/membership/fee required)
• Swets Information Services - full-text online (subscription/membership/fee required)

Subjects

• Drug Industry
• Government Regulation
• Humans
• Organizational Innovation
• Risk Assessment
• Risk Sharing, Financial

Similar articles

• Today's conflict of interest compliance challenge: how do we balance the commitment to integrity with the demand for innovation? (2008-08-22)
• Restrictions on interactions between doctors and industry could ultimately hurt patients. (2011-08-29)
• Impact of the new US health-care-reform legislation on the pharmaceutical industry: who are the real winners? (2010-10-20)
• Communication about results of comparative effectiveness studies: a pharmaceutical industry view. (2012-10-10)
• The Antidepressant WebMarketing depression and making medicines work. (1997-01-01)
• Tobacco industry sponsorship of a book and conflict of interest. (2006-07-27)
• Shining the light on physician-pharmaceutical and medical device industry financial relationships. (2011-08-29)
• The implementation of REACH: initial perspectives from government, industry, and civil society. (2011-02-24)
• Posing a framework to guide government's role in payment and delivery system reform. (2012-09-05)

Authors

• R A Epstein

Publication date

2007-07-16

Journal

Journal topics

• Drug Therapy
• Pharmacology

Language

Eng.

Copyright

Clinical pharmacology and therapeutics

School of Law, University of Chicago, Chicago, Illinois, USA. repstein [at] uchicago.edu

Release reference

Clin Pharmacol Ther. 2007 Aug;82(2):131-2

Related books

• Books of Drug Industry
• Books of Drug Therapy
• Books of Government Regulation
• Books of Organizational Innovation
• Books of Pharmacology
• Books of Risk Assessment
• Books of Risk Sharing, Financial